All AI training jobs

Mercor · Open to all

Urologists & Medical Oncologists (Prostate Cancer) – Paid Research Study

Listed on Mercor as “Urologists & Medical Oncologists (Prostate Cancer) - Paid Research Study”

$175/hrRemoteContractPaid in USD
ShareWhatsAppTelegramEmail

What this actually is

You complete short labeling tasks, record everyday activities, or evaluate AI outputs across general knowledge domains. Open to most backgrounds. The platform title (Urologists & Medical Oncologists (Prostate Cancer) - Paid Research Study) reflects the rate band and the expertise required, not the day-to-day work.

Advertisement

Can you do this on your visa?

F-2 / F-4 / F-5 / F-6: open. E-1 to E-7: needs concurrent-employment permit. D-2 / D-4 students: S-3 permit, 20 hr/week cap. D-10 / D-8: case by case.

Korean tax on USD income

First 5 years in Korea: foreign-source income only taxed if remitted into Korea. After year 5: worldwide income. Full tax guide.

Original posting from Mercor

Mercor is conducting a paid research study in collaboration with a leading AI research lab focused on improving healthcare. We are seeking board-certified urologists and medical oncologists in the United States who manage patients with metastatic prostate cancer to take part in a short online survey about treatment decision-making.

Responsibilities

Participants will be asked to:

  • Complete a structured ~30-minute online survey
  • Share perspectives on how you evaluate and select systemic treatments for patients with prostate cancer
  • Submit all responses within the given timeline

Requirements

  • Urologist or medical oncologist with an MD or DO
  • Board certified in your specialty
  • Hold an active, unrestricted US medical license and practice primarily in the United States
  • Spend at least 25% of your professional time in direct patient care
  • Have cared for prostate-cancer patients in the past 12 months, including at least one patient with metastatic hormone-sensitive (mHSPC) or castration-resistant (mCRPC) prostate cancer
  • Regularly manage metastatic prostate cancer, with primary or shared responsibility for selecting systemic treatment
  • Able to independently complete a ~30-minute online survey

Please note: this study is not open to anyone who has taken part in prostate-cancer market research in the past 3 months, or who (or whose immediate family) works for a pharmaceutical, diagnostics, market research, or advertising company, a wholesaler, or a specialty pharmacy.

Engagement Details

  • Format: Online survey
  • Duration: Approximately 30 minutes
  • Compensation: One-time payment upon successful verification of the submission
  • Location: Remote (United States)

Why Participate

  • Contribute to research shaping the next generation of healthcare AI tools
  • Share your real-world clinical expertise in managing advanced prostate cancer

Quoted from Mercor’s public listing on 2026-10-06. We don’t edit platform copy; honest framing is in the title and the “what this actually is” block above.

Apply on Mercor